Disposable sterile insulin injectors are indispensable medical devices in diabetes treatment, and their quality directly affects patient safety and treatment efficacy.
Insulin, as a protein hormone, has extremely stringent requirements for injection precision, sterility, and biocompatibility. Substandard injectors can lead to serious medical risks such as dosage errors, microbial infections, and tissue damage. With the continued rise in global diabetes prevalence, the production and use of insulin injectors are increasing year by year, making rigorous testing a crucial line of defense for protecting the lives of millions of patients. Testing not only involves the quality control systems of manufacturers but is also a core component of market access and supervision by medical device regulatory agencies, spanning the entire lifecycle from product development and raw material procurement to production process monitoring and final product release.
